Anavex Life Sciences Corporation

AVXL NASDAQ Healthcare & Biotech United States US0327973006
3.65 $
17.36 %

Anavex Life Sciences Corporation is engaged in the development of next-generation treatments for neurological and neurodegenerative diseases.